Enhanced Axonal Metabolism during Early Natalizumab Treatment in Relapsing-Remitting Multiple SclerosisOliver T. Wiebenga, Jeroen J.G. Geurts, Martijn D. Steenwijk et al.|American Journal of Neuroradiology|2015Cited by 17
White Matter Diffusion Changes during the First Year of Natalizumab Treatment in Relapsing-Remitting Multiple SclerosisOliver T. Wiebenga, Jeroen J.G. Geurts, Menno M. Schoonheim et al.|American Journal of Neuroradiology|2016Cited by 12